From process development to GMP execution, effective handoffs can make a difference. Learn how biopharma teams can strengthen readiness and reduce challenges before clinical manufacturing begins. pharmafocuseurope.com/promot… #GMP #Biopharma #CDMO #DrugDevelopment

💊 October 2026 Pharma Industry Insights is here! Discover the latest pharma innovations, drug development trends, manufacturing advances & global market updates. Read the E-Newsletter: industry.pharmafocuseurope.c… #Pharma #PharmaNews

Gene therapy offers the promise of one-time, potentially curative treatments—but how do we monitor safety risks that may emerge years later? Discover why pharmacovigilance needs a new approach. 🔗pharmafocuseurope.com/articl… #GeneTherapy #DrugSafety

What does it take to make a bioprocess reproducible from one run to the next? INFORS HT has introduced Multifors 3, a new bench-top bioreactor designed to help scientists carry the complete control strategy from one run to the next. infors-ht.com/en/products/bi… #Bioprocessing

Regulatory approval is just the beginning. Explore how pharma companies can navigate Europe’s pricing, reimbursement, HTA requirements, and payer expectations to improve market access and patient reach. 🔗 pharmafocuseurope.com/articl… #MarketAccess #Pharma

Sanner Group combines 130+ years of patient-first expertise with pharmaceutical packaging and medical device capabilities, backed by global quality, local expertise and security of supply. Learn more: industry.pharmafocuseurope.c… #Pharma #Packaging #MedicalDevices

From process development to GMP execution, effective handoffs can make a difference. Learn how biopharma teams can strengthen readiness and reduce challenges before clinical manufacturing begins. pharmafocuseurope.com/promot… #GMP #Biopharma #CDMO #DrugDevelopment

How can biotech innovation reach patients faster? Strategic biotech–pharma partnerships combine scientific expertise, development capabilities, and shared risk to turn promising discoveries into medicines. 🔗 pharmafocuseurope.com/articl… #Biotech #Pharma

Clinical research doesn’t end when a trial does. Discover why transparent reporting, responsible data sharing, and effective dissemination are essential to research accountability and public trust. 🔗 pharmafocuseurope.com/articl… #ClinicalTrials #ClinicalResearch

How is M&A reshaping Europe’s pharmaceutical pipeline? Discover how acquisitions are helping pharma companies access external innovation, strengthen drug pipelines, and navigate a competitive market. Read more: pharmafocuseurope.com/articl… #Pharma #MandA

Real-World Evidence (RWE) is moving beyond its traditional post-market —supporting drug development, regulatory decisions, evidence generation and market access through real-world data. 🔗 pharmafocuseurope.com/articl… #RWE #Pharma #DrugDevelopment

Adaptive Trial Designs are reshaping clinical development by enabling data-driven adaptations, early stopping, smarter dose selection and faster go/no-go decisions. 🔗 pharmafocuseurope.com/articl… #AdaptiveTrials #ClinicalDevelopment #Pharma

What does it take to make a bioprocess reproducible from one run to the next? INFORS HT has introduced Multifors 3, a new bench-top bioreactor designed to help scientists carry the complete control strategy from one run to the next. infors-ht.com/en/products/bi… #Bioprocessing

Oligonucleotide therapeutics are entering high-volume markets, creating a new manufacturing challenge: scaling from kilograms to tonnes while controlling cost, quality and environmental impact. pharmafocuseurope.com/articl… #Oligonucleotides #Pharma #Biopharma

Moving from biopharma development to GMP manufacturing requires more than process transfer. Strong knowledge sharing, cross-functional alignment and operational readiness are key to a smoother path to clinical production. pharmafocuserope.com/promoti… #Biopharma #GMP

EU Pharmaceutical Law shapes the compliance and regulatory obligations of pharma companies across Europe. Learn about key legislation, legal requirements and EU Pharma Compliance. 🔗 pharmafocuseurope.com/articl… #EUPharmaceuticalLaw #PharmaCompliance

Blockchain is reshaping pharma supply-chain visibility—extending traceability beyond pack verification to custody transfers, cold-chain integrity, compliance, recalls, and security. pharmafocuseurope.com/articl… #Blockchain #Pharma #DrugTraceability

What does it take to make a bioprocess reproducible from one run to the next? INFORS HT has introduced Multifors 3, a new bench-top bioreactor designed to help scientists carry the complete control strategy from one run to the next. infors-ht.com/en/products/bi… #Bioprocessing

Measuring Digital Channels’ ROI in Pharma Marketing Praveen Radhakrishnan, Manager – Strategic Initiatives at Indegene, explores a data-driven framework for measuring digital ROI, attribution, HCP engagement & commercial impact. 🔗 pharmafocuseurope.com/articl… #DigitalROI #Life

From DARWIN EU and federated data networks to the European Health Data Space and EU HTA frameworks, RWE is strengthening evidence generation across the medicine lifecycle. 🔗 pharmafocuseurope.com/articl… #RWE #Pharma #DrugDevelopment #Healthcare #LifeSciences